annual operating expenses:
$5.09B+$795.10M(+18.49%)Summary
- As of today (May 21, 2025), VRTX annual total operating expenses is $5.09 billion, with the most recent change of +$795.10 million (+18.49%) on December 31, 2024.
- During the last 3 years, VRTX annual operating expenses has risen by +$1.20 billion (+30.93%).
- VRTX annual operating expenses is now at all-time high.
Performance
VRTX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$1.38B-$200.00K(-0.01%)Summary
- As of today (May 21, 2025), VRTX quarterly total operating expenses is $1.38 billion, with the most recent change of -$200.00 thousand (-0.01%) on March 31, 2025.
- Over the past year, VRTX quarterly operating expenses has increased by +$244.30 million (+21.59%).
- VRTX quarterly operating expenses is now -14.09% below its all-time high of $1.60 billion, reached on June 30, 2021.
Performance
VRTX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VRTX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.5% | +21.6% |
| 3 y3 years | +30.9% | +68.6% |
| 5 y5 years | +111.1% | +118.2% |
VRTX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.2% | -0.0% | +68.8% |
| 5 y | 5-year | at high | +111.1% | -14.1% | +124.6% |
| alltime | all time | at high | >+9999.0% | -14.1% | >+9999.0% |
VRTX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.38B(-0.0%) |
| Dec 2024 | $5.09B(+18.5%) | $1.38B(+10.3%) |
| Sep 2024 | - | $1.25B(-6.8%) |
| Jun 2024 | - | $1.34B(+18.3%) |
| Mar 2024 | - | $1.13B(-5.2%) |
| Dec 2023 | $4.30B(+23.4%) | $1.19B(+11.2%) |
| Sep 2023 | - | $1.07B(+2.4%) |
| Jun 2023 | - | $1.05B(+6.6%) |
| Mar 2023 | - | $983.70M(+2.3%) |
| Dec 2022 | $3.48B(-10.4%) | $961.50M(+7.8%) |
| Sep 2022 | - | $891.80M(+9.4%) |
| Jun 2022 | - | $815.40M(-0.1%) |
| Mar 2022 | - | $816.30M(-14.0%) |
| Dec 2021 | $3.89B(+49.7%) | $949.50M(+37.2%) |
| Sep 2021 | - | $691.90M(-56.8%) |
| Jun 2021 | - | $1.60B(+147.1%) |
| Mar 2021 | - | $648.10M(-4.5%) |
| Dec 2020 | $2.60B(+7.7%) | $678.43M(+0.1%) |
| Sep 2020 | - | $678.05M(+10.7%) |
| Jun 2020 | - | $612.73M(-2.9%) |
| Mar 2020 | - | $630.79M(-6.6%) |
| Dec 2019 | $2.41B(+22.2%) | $675.25M(-5.6%) |
| Sep 2019 | - | $715.62M(+33.6%) |
| Jun 2019 | - | $535.59M(+10.1%) |
| Mar 2019 | - | $486.54M(-17.7%) |
| Dec 2018 | $1.97B(+8.4%) | $591.09M(+26.4%) |
| Sep 2018 | - | $467.81M(-1.5%) |
| Jun 2018 | - | $474.83M(+7.8%) |
| Mar 2018 | - | $440.36M(-0.2%) |
| Dec 2017 | $1.82B(+23.0%) | $441.46M(-23.3%) |
| Sep 2017 | - | $575.66M(+38.1%) |
| Jun 2017 | - | $416.70M(+7.7%) |
| Mar 2017 | - | $386.89M(+8.0%) |
| Dec 2016 | $1.48B(+7.9%) | $358.36M(-5.3%) |
| Sep 2016 | - | $378.43M(-1.1%) |
| Jun 2016 | - | $382.66M(+6.0%) |
| Mar 2016 | - | $361.07M(-11.2%) |
| Dec 2015 | $1.37B(+18.2%) | $406.73M(+17.5%) |
| Sep 2015 | - | $346.06M(+8.7%) |
| Jun 2015 | - | $318.25M(+5.6%) |
| Mar 2015 | - | $301.46M(+7.7%) |
| Dec 2014 | $1.16B(-6.2%) | $279.99M(+5.2%) |
| Sep 2014 | - | $266.16M(-11.8%) |
| Jun 2014 | - | $301.93M(-3.5%) |
| Mar 2014 | - | $312.83M(+0.4%) |
| Dec 2013 | $1.24B(+3.3%) | $311.52M(+1.8%) |
| Sep 2013 | - | $305.87M(-7.0%) |
| Jun 2013 | - | $328.98M(+5.8%) |
| Mar 2013 | - | $310.97M(+11.4%) |
| Dec 2012 | $1.20B(+8.1%) | $279.17M(-6.3%) |
| Sep 2012 | - | $297.85M(-5.2%) |
| Jun 2012 | - | $314.06M(+2.1%) |
| Mar 2012 | - | $307.52M(-0.3%) |
| Dec 2011 | $1.11B(+34.3%) | $308.32M(+2.9%) |
| Sep 2011 | - | $299.71M(+10.9%) |
| Jun 2011 | - | $270.27M(+17.4%) |
| Mar 2011 | - | $230.13M(-0.5%) |
| Dec 2010 | $825.22M(+21.3%) | $231.37M(+5.5%) |
| Sep 2010 | - | $219.29M(+11.9%) |
| Jun 2010 | - | $196.00M(+9.8%) |
| Mar 2010 | - | $178.56M(+6.4%) |
| Dec 2009 | $680.47M(+10.1%) | $167.80M(-0.5%) |
| Sep 2009 | - | $168.70M(-1.8%) |
| Jun 2009 | - | $171.86M(-0.1%) |
| Mar 2009 | - | $172.10M(+1.9%) |
| Dec 2008 | $618.20M | $168.82M(+7.4%) |
| Sep 2008 | - | $157.16M(+0.7%) |
| Jun 2008 | - | $156.02M(+14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $136.21M(-1.9%) |
| Dec 2007 | $597.78M(+39.2%) | $138.79M(-7.7%) |
| Sep 2007 | - | $150.37M(-5.7%) |
| Jun 2007 | - | $159.51M(+7.0%) |
| Mar 2007 | - | $149.12M(+19.3%) |
| Dec 2006 | $429.57M(+46.8%) | $124.98M(+12.7%) |
| Sep 2006 | - | $110.89M(+5.0%) |
| Jun 2006 | - | $105.62M(+19.9%) |
| Mar 2006 | - | $88.08M(+8.8%) |
| Dec 2005 | $292.53M(+24.9%) | $80.97M(+8.9%) |
| Sep 2005 | - | $74.33M(+5.9%) |
| Jun 2005 | - | $70.17M(+4.6%) |
| Mar 2005 | - | $67.06M(+1.8%) |
| Dec 2004 | $234.30M(-1.9%) | $65.90M(+11.0%) |
| Sep 2004 | - | $59.39M(+3.1%) |
| Jun 2004 | - | $57.61M(+12.1%) |
| Mar 2004 | - | $51.40M(-12.6%) |
| Dec 2003 | $238.72M(-0.3%) | $58.77M(-0.5%) |
| Sep 2003 | - | $59.06M(-43.8%) |
| Jun 2003 | - | $105.05M(<-9900.0%) |
| Mar 2003 | - | -$112.00K(-100.2%) |
| Dec 2002 | $239.39M(+21.6%) | $57.83M(-9.0%) |
| Sep 2002 | - | $63.55M(+6.1%) |
| Jun 2002 | - | $59.89M(+3.1%) |
| Mar 2002 | - | $58.12M(+5.1%) |
| Dec 2001 | $196.80M(+36.9%) | $55.29M(+10.1%) |
| Sep 2001 | - | $50.22M(+32.3%) |
| Jun 2001 | - | $37.97M(+13.0%) |
| Mar 2001 | - | $33.62M(-41.9%) |
| Dec 2000 | $143.79M(+37.5%) | $57.81M(+91.4%) |
| Sep 2000 | - | $30.20M(+5.6%) |
| Jun 2000 | - | $28.59M(+5.3%) |
| Mar 2000 | - | $27.16M(-4.7%) |
| Dec 1999 | $104.60M(+28.5%) | $28.50M(+16.3%) |
| Sep 1999 | - | $24.50M(-5.4%) |
| Jun 1999 | - | $25.91M(+1.2%) |
| Mar 1999 | - | $25.60M(+0.4%) |
| Dec 1998 | $81.40M(+22.2%) | $25.50M(+18.1%) |
| Sep 1998 | - | $21.60M(+20.7%) |
| Jun 1998 | - | $17.90M(+9.1%) |
| Mar 1998 | - | $16.40M(-12.3%) |
| Dec 1997 | $66.60M(+8.6%) | $18.70M(-7.4%) |
| Sep 1997 | - | $20.20M(+42.3%) |
| Jun 1997 | - | $14.20M(+6.8%) |
| Mar 1997 | - | $13.30M(-48.8%) |
| Dec 1996 | $61.30M(+17.2%) | $26.00M(+134.2%) |
| Sep 1996 | - | $11.10M(-9.8%) |
| Jun 1996 | - | $12.30M(+3.4%) |
| Mar 1996 | - | $11.90M(+3.5%) |
| Dec 1995 | $52.30M(+19.4%) | $11.50M(+1.8%) |
| Sep 1995 | - | $11.30M(-35.4%) |
| Jun 1995 | - | $17.50M(+45.8%) |
| Mar 1995 | - | $12.00M(-0.8%) |
| Dec 1994 | $43.80M(+43.1%) | $12.10M(+9.0%) |
| Sep 1994 | - | $11.10M(0.0%) |
| Jun 1994 | - | $11.10M(+14.4%) |
| Mar 1994 | - | $9.70M(-7.6%) |
| Dec 1993 | $30.60M(+84.3%) | $10.50M(+28.0%) |
| Sep 1993 | - | $8.20M(+26.2%) |
| Jun 1993 | - | $6.50M(+25.0%) |
| Mar 1993 | - | $5.20M(+13.0%) |
| Dec 1992 | $16.60M(+56.6%) | $4.60M(+7.0%) |
| Sep 1992 | - | $4.30M(+230.8%) |
| Jun 1992 | - | $1.30M(-63.9%) |
| Mar 1992 | - | $3.60M(+20.0%) |
| Dec 1991 | $10.60M(+65.6%) | $3.00M(+15.4%) |
| Sep 1991 | - | $2.60M(0.0%) |
| Jun 1991 | - | $2.60M |
| Dec 1990 | $6.40M | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual operating expenses year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total operating expenses?
The current annual operating expenses of VRTX is $5.09B
What is the all time high annual operating expenses for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total operating expenses is $5.09B
What is Vertex Pharmaceuticals Incorporated annual operating expenses year-on-year change?
Over the past year, VRTX annual total operating expenses has changed by +$795.10M (+18.49%)
What is Vertex Pharmaceuticals Incorporated quarterly total operating expenses?
The current quarterly operating expenses of VRTX is $1.38B
What is the all time high quarterly operating expenses for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total operating expenses is $1.60B
What is Vertex Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
Over the past year, VRTX quarterly total operating expenses has changed by +$244.30M (+21.59%)